Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Invest Ophthalmol Vis Sci
2011 Jul 29;528:5749-57. doi: 10.1167/iovs.10-6825.
Show Gene links
Show Anatomy links
Transport via SLC5A8 (SMCT1) is obligatory for 2-oxothiazolidine-4-carboxylate to enhance glutathione production in retinal pigment epithelial cells.
Babu E
,
Ananth S
,
Veeranan-Karmegam R
,
Coothankandaswamy V
,
Smith SB
,
Boettger T
,
Ganapathy V
,
Martin PM
.
???displayArticle.abstract???
To evaluate the role of SLC5A8 in the transport of 2-oxothiazolidine-4-carboxylate (OTC) and to determine whether OTC augments glutathione production in RPE cells, thereby providing protection against oxidative stress. SLC5A8-mediated transport of OTC was monitored in Xenopus laevis oocytes by electrophysiological means. Saturation kinetics, Na(+)-activation kinetics, and inhibition by ibuprofen were analyzed by monitoring OTC-induced currents as a measure of transport activity. Oxidative stress was induced in ARPE-19 cells and primary RPE cells isolated from wild type and Slc5a8(-/-) mouse retinas using H(2)O(2), and the effects of OTC on cell death and intracellular glutathione concentration were examined. Heterologous expression of human SLC5A8 in X. laevis oocytes induced Na(+)-dependent inward currents in the presence of OTC under voltage-clamp conditions. The transport of OTC via SLC5A8 was saturable, with a K(t) of 104 ± 3 μM. The Na(+)-activation kinetics was sigmoidal with a Hill coefficient of 1.9 ± 0.1, suggesting involvement of two Na(+) in the activation process. Ibuprofen, a blocker of SLC5A8, inhibited SLC5A8-mediated OTC transport; the concentration necessary for half-maximal inhibition was 17 ± 1 μM. OTC increased glutathione levels and protected ARPE-19 and primary RPE cells isolated from wild type mouse retinas from H(2)O(2)-induced cell death. These effects were abolished in primary RPE isolated from Slc5a8(-/-) mouse retinas. OTC is a transportable substrate for SLC5A8. OTC augments glutathione production in RPE cells, thereby protecting them from oxidative damage. Transport via SLC5A8 is obligatory for this process.
Ambati,
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.
2003,
Pubmed
Anderson,
Marked increase of cysteine levels in many regions of the brain after administration of 2-oxothiazolidine-4-carboxylate.
1989,
Pubmed
Barditch-Crovo,
A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus.
1998,
Pubmed
Beatty,
The role of oxidative stress in the pathogenesis of age-related macular degeneration.
2000,
Pubmed
Bridges,
Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.
2001,
Pubmed
Brodeur,
Effect of a cysteine prodrug, L-2-oxothiazolidine-4-carboxylic acid, on the metabolism and toxicity of bromobenzene: an acute study.
1987,
Pubmed
Cai,
Oxidative damage and protection of the RPE.
2000,
Pubmed
Cohen,
Low glutathione reductase and peroxidase activity in age-related macular degeneration.
1994,
Pubmed
Davidson,
Synthesis and transport of glutathione by cultured human retinal pigment epithelial cells.
1994,
Pubmed
Ding,
Molecular pathology of age-related macular degeneration.
2009,
Pubmed
FUTTERMAN,
Metabolism of the retina. I. Respiration of cattle retina.
1959,
Pubmed
Frank,
Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration.
1999,
Pubmed
Frank,
Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice.
2008,
Pubmed
Ganapathy,
Transport of glycyl-L-proline into intestinal and renal brush border vesicles from rabbit.
1981,
Pubmed
Ganapathy,
Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.
2008,
Pubmed
Ganea,
Glutathione-related enzymes and the eye.
2006,
Pubmed
Gnana-Prakasam,
Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.
2009,
Pubmed
Gopal,
Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.
2007,
Pubmed
,
Xenbase
Ho,
L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes.
1997,
Pubmed
Holmes,
The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion.
1997,
Pubmed
Itagaki,
Interaction of ibuprofen and other structurally related NSAIDs with the sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8).
2006,
Pubmed
,
Xenbase
Kannan,
Glutathione transport in human retinal pigment epithelial (HRPE) cells: apical localization of sodium-dependent gsh transport.
2001,
Pubmed
Lee,
A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma.
2005,
Pubmed
Lu,
Bidirectional glutathione transport by cultured human retinal pigment epithelial cells.
1995,
Pubmed
Martin,
Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain.
2006,
Pubmed
,
Xenbase
Martin,
Expression of the sodium-coupled monocarboxylate transporters SMCT1 (SLC5A8) and SMCT2 (SLC5A12) in retina.
2007,
Pubmed
Martin,
Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.
2009,
Pubmed
Mesina,
Administration of L-2-oxothiazolidine-4-carboxylate increases glutathione levels in rat brain.
1989,
Pubmed
Miceli,
Glucose uptake, hexose monophosphate shunt activity, and oxygen consumption in cultured human retinal pigment epithelial cells.
1990,
Pubmed
Miyauchi,
Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids.
2004,
Pubmed
,
Xenbase
Miyauchi,
Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter.
2010,
Pubmed
,
Xenbase
Moberly,
Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (Procysteine).
1998,
Pubmed
Moriarty,
Oxidation of glutathione and cysteine in human plasma associated with smoking.
2003,
Pubmed
Moslen,
Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
1989,
Pubmed
Olney,
Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine.
1970,
Pubmed
Porta,
L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human.
1991,
Pubmed
Samiec,
Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes.
1998,
Pubmed
Singh,
Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases.
2010,
Pubmed
Sternberg,
Protection of retinal pigment epithelium from oxidative injury by glutathione and precursors.
1993,
Pubmed
Vita,
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
1998,
Pubmed
Wernerman,
Modulation of endogenous glutathione availability.
1999,
Pubmed
Williamson,
Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis.
1982,
Pubmed
Williamson,
Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate.
1981,
Pubmed
Winkler,
Oxidative damage and age-related macular degeneration.
1999,
Pubmed
